How Matrix Metalloproteinases Regulate Cell Behavior
Tóm tắt
▪ Abstract The matrix metalloproteinases (MMPs) constitute a multigene family of over 25 secreted and cell surface enzymes that process or degrade numerous pericellular substrates. Their targets include other proteinases, proteinase inhibitors, clotting factors, chemotactic molecules, latent growth factors, growth factor–binding proteins, cell surface receptors, cell-cell adhesion molecules, and virtually all structural extracellular matrix proteins. Thus MMPs are able to regulate many biologic processes and are closely regulated themselves. We review recent advances that help to explain how MMPs work, how they are controlled, and how they influence biologic behavior. These advances shed light on how the structure and function of the MMPs are related and on how their transcription, secretion, activation, inhibition, localization, and clearance are controlled. MMPs participate in numerous normal and abnormal processes, and there are new insights into the key substrates and mechanisms responsible for regulating some of these processes in vivo. Our knowledge in the field of MMP biology is rapidly expanding, yet we still do not fully understand how these enzymes regulate most processes of development, homeostasis, and disease.
Từ khóa
Tài liệu tham khảo
Barcellos-Hoff MH, 2000, Cancer Res., 60, 1254
Edwards DR. 2001.The tissue inhibitors of metalloproteinases (TIMPs).InMatrix Metalloproteinase Inhibitors in Cancer Therapy, ed. NJ Clendeninn, K Appelt. pp. 67–84. Totowa, NJ: Humana
Fingleton B, 1999, Clin. Exp. Metastasis, 17, 769
Gomez DE, 1997, Eur. J. Cell Biol., 74, 111
Guo H, 2000, Cancer Res., 60, 888
Ha HY, 2001, Cancer Res., 61, 984
Imai K, 1996, Cancer Res., 56, 2707
Itoh T, 1998, Cancer Res., 58, 1048
Kanamori Y, 1999, Cancer Res., 59, 4225
Koop S, 1994, Cancer Res., 54, 4791
Martin DC, 1996, Oncogene, 13, 569
Mitsiades N, 2001, Cancer Res., 61, 577
Moinfar F, 2000, Cancer Res., 60, 2562
Overall CM. 2001.Matrix metalloproteinase substrate binding domains, modules and exosites.InMatrix Metalloproteinase Protocols, ed. IM Clark, pp. 79–120. Totowa, NJ: Humana
Petitclerc E, 1999, Cancer Res., 59, 2724
Rudolph-Owen LA, 1998, Cancer Res., 58, 5500
Rutter JL, 1998, Cancer Res., 58, 5321
Sheu BC, 2001, Cancer Res., 61, 237
Soloway PD, 1996, Oncogene, 13, 2307
Sternlicht MD, Coussens LM, Vu TH, Werb Z. 2001.Biology and regulation of the matrix metalloproteinases.InMatrix Metalloproteinase Inhibitors in Cancer Therapy, ed. NJ Clendeninn, K Appelt, pp. 1–37. Totowa, NJ: Humana
Sternlicht MD, Werb Z. 1999.ECM proteinases.InGuidebook to the Extracellular Matrix,Anchor and Adhesion Proteins, ed. T Kreis, R Vale, pp. 503–62. Oxford, UK: Oxford Univ. Press
Stricker TP, 2000, Mol. Biol. Cell, 11, 258a
Uria JA, 2000, Cancer Res., 60, 4745
Vincenti MP. 2001.The matrix metalloproteinase (MMP) and tissue inhibitor of metalloproteinase (TIMP) genes.InMatrix Metalloproteinase Protocols, ed. IM Clark, pp. 121–48. Totowa, NJ: Humana